SCHEMBL5028264

SCHEMBL5028264

c1cc(-c2cc(-n3c4ccccc4c4ccccc43)cc3c2oc2ccccc23)cc(-c2cc(-n3c4ccccc4c4ccccc43)cc3c2oc2ccccc23)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 3/20 0.45
GGPS1 O95749 1/20 0.39
ATM Q13315 2/20 0.39
KDM4E B2RXH2 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
AHR P35869 1/20 0.38
PRKDC P78527 6/20 0.36
PTGES2 Q9H7Z7 1/20 0.36
PLA2G2A P14555 2/20 0.34
PLA2G4A P47712 2/20 0.34
PRMT5 O14744 1/20 0.34
WDR77 Q9BQA1 1/20 0.34
PIK3CD O00329 1/20 0.32
PIK3CB P42338 1/20 0.32
ALDH1A1 P00352 1/20 0.32
LMNA P02545 1/20 0.32
PPARG P37231 1/20 0.32
RXFP1 Q9HBX9 1/20 0.32
NR2E3 Q9Y5X4 1/20 0.32
NCOR2 Q9Y618 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17057165 0.95 ALOX5 (0.44) ALOX5GGPS1ATMKDM4EL3MBTL1
SCHEMBL5028255 0.95 ALOX5 (0.43) ALOX5GGPS1ATMKDM4EL3MBTL1
SCHEMBL24739517 0.93 KDM4E (0.43) ALOX5GGPS1ATMKDM4EL3MBTL1
SCHEMBL17166661 0.92 ALOX5 (0.39) ALOX5GGPS1ATMKDM4EL3MBTL1
SCHEMBL5028179 0.92 ALOX5 (0.47) ALOX5GGPS1ATMKDM4EL3MBTL1
SCHEMBL17057289 0.91 ALOX5 (0.41) ALOX5GGPS1ATMKDM4EL3MBTL1
SCHEMBL16582806 0.91 ALOX5 (0.38) ALOX5GGPS1ATMKDM4EL3MBTL1
SCHEMBL14733738 0.90 KDM4E (0.44) ALOX5ATMKDM4EL3MBTL1AHR
SCHEMBL22181960 0.89 ALOX5 (0.40) ALOX5GGPS1ATMKDM4EL3MBTL1
SCHEMBL12925588 0.89 ALOX5 (0.45) ALOX5GGPS1ATMKDM4EL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2453496-A1 ORGANIC ELECTROLUMINESCENT ELEMENT, NOVEL COMPOUND, LIGHTING DEVICE AND DISPLAY DEVICE Konica Minolta Holdings, Inc. (JP) 2012-05-16 EP disclosed
US-20110006670-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT, NEW COMPOUND FOR THE SAME, DISPLAY DEVICE AND LIGHTING DEVICE USING THE SAME KONICA MINOLTA HOLDINGS, INC. (JP) 2011-01-13 US disclosed
US-20110006670-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT, NEW COMPOUND FOR THE SAME, DISPLAY DEVICE AND LIGHTING DEVICE USING THE SAME KONICA MINOLTA HOLDINGS, INC. (JP) 2011-01-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110006670-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT, NEW COMPOUND FOR THE SAME, DISPLAY DEVICE AND LIGHTING DEVICE USING THE SAME AOC2, AOC3, CDYL ALOX5 855/4885GGPS1 2906/4885ATM 3194/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.